Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 3
1995 1
1996 4
1997 4
1998 7
1999 5
2000 7
2001 4
2002 4
2003 9
2004 6
2005 10
2006 21
2007 23
2008 21
2009 37
2010 50
2011 58
2012 66
2013 92
2014 100
2015 87
2016 79
2017 66
2018 74
2019 63
2020 58
2021 68
2022 39
Text availability
Article attribute
Article type
Publication date

Search Results

940 results
Results by year
Filters applied: . Clear all
Page 1
Agomelatine.
[No authors listed] [No authors listed] 2021 Jun 21. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Jun 21. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 34165944 Free Books & Documents. Review.
Agomelatine is not approved for marketing in the United States by the U.S. ...
Agomelatine is not approved for marketing in the United States by the U.S. ...
Agomelatine for depression: expanding the horizons?
Norman TR, Olver JS. Norman TR, et al. Expert Opin Pharmacother. 2019 Apr;20(6):647-656. doi: 10.1080/14656566.2019.1574747. Epub 2019 Feb 13. Expert Opin Pharmacother. 2019. PMID: 30759026 Review.
Agomelatine is an antidepressant with unique pharmacological actions; it is both a melatonin agonist and selective serotonin antagonist. ...Bipolar depression and seasonal affective disorder may also react favourably. Agomelatine may have specific efficacy on sympto
Agomelatine is an antidepressant with unique pharmacological actions; it is both a melatonin agonist and selective serotonin antagoni
Agomelatine in depression.
Smeraldi E, Delmonte D. Smeraldi E, et al. Expert Opin Drug Saf. 2013 Nov;12(6):873-80. doi: 10.1517/14740338.2013.828690. Epub 2013 Sep 16. Expert Opin Drug Saf. 2013. PMID: 24033095 Review.
It may be a valuable pharmacological alternative in the clinical approach on depression. AREAS COVERED: The literature about agomelatine has been comprehensively reviewed. Agomelatine's efficacy, safety and tolerability are reviewed based on the studies undertaken i …
It may be a valuable pharmacological alternative in the clinical approach on depression. AREAS COVERED: The literature about agomelatine
The preclinical discovery and development of agomelatine for the treatment of depression.
Konstantakopoulos G, Dimitrakopoulos S, Michalopoulou PG. Konstantakopoulos G, et al. Expert Opin Drug Discov. 2020 Oct;15(10):1121-1132. doi: 10.1080/17460441.2020.1781087. Epub 2020 Jun 22. Expert Opin Drug Discov. 2020. PMID: 32568567 Review.
AREAS COVERED: The aim of this case history is to describe the discovery strategy and development of agomelatine. The pharmacodynamic profile of the drug is briefly presented. ...EXPERT OPINION: There is now evidence supporting the clinical efficacy and safety profile of …
AREAS COVERED: The aim of this case history is to describe the discovery strategy and development of agomelatine. The pharmacodynamic …
Agomelatine confers neuroprotection against cisplatin-induced hippocampal neurotoxicity.
Cankara FN, Günaydın C, Çelik ZB, Şahin Y, Pekgöz Ş, Erzurumlu Y, Gülle K. Cankara FN, et al. Metab Brain Dis. 2021 Feb;36(2):339-349. doi: 10.1007/s11011-020-00634-y. Epub 2020 Nov 9. Metab Brain Dis. 2021. PMID: 33165734
Additionally, agomelatine treatment inhibited cisplatin-induced behavioral deficits and neuronal integrity in vivo. ...Agomelatine significantly attenuated oxidative stress and inflammation due to the cisplatin insult in vitro and in vivo. ...
Additionally, agomelatine treatment inhibited cisplatin-induced behavioral deficits and neuronal integrity in vivo. ...Agomelatine
Focus on agomelatine.
Green B. Green B. Curr Med Res Opin. 2011 Apr;27(4):745-9. doi: 10.1185/03007995.2011.554534. Epub 2011 Jan 27. Curr Med Res Opin. 2011. PMID: 21271795 Review.
SCOPE: This is a review of current evidence for clinical efficacy and safety, drawn from a literature review using Medline and PsycInfo in 2010 using search terms including agomelatine, melatonergic antidepressant and Valdoxan. FINDINGS: Agomelatine has antidepressa …
SCOPE: This is a review of current evidence for clinical efficacy and safety, drawn from a literature review using Medline and PsycInfo in 2 …
Antidepressant efficacy of Agomelatine: Meta-analysis of placebo controlled and active comparator studies.
Maddukuri RK, Hema C, Sri Tejaswi K, Venkata Mounika M, Vegesana BP. Maddukuri RK, et al. Asian J Psychiatr. 2021 Nov;65:102866. doi: 10.1016/j.ajp.2021.102866. Epub 2021 Sep 20. Asian J Psychiatr. 2021. PMID: 34592623 Review.
Agomelatine is a novel antidepressant that was developed to counter the adverse effects associated with the standard SSRIs and SNRIs that limited their usage. ...In comparison (RR 0.99, 0.92-1.07) Agomelatine is an effective antidepressant having similar efficacy wi
Agomelatine is a novel antidepressant that was developed to counter the adverse effects associated with the standard SSRIs and SNRIs
Agomelatine for the treatment of generalized anxiety disorder.
Buoli M, Grassi S, Serati M, Altamura AC. Buoli M, et al. Expert Opin Pharmacother. 2017 Sep;18(13):1373-1379. doi: 10.1080/14656566.2017.1359257. Epub 2017 Jul 28. Expert Opin Pharmacother. 2017. PMID: 28730851 Review.
Agomelatine is a melatonergic antidepressant, approved for the treatment of Major Depressive Disorder (MDD) in Europe and Australia, but not in the United States. ...In addition, agomelatine has not been associated with potential risk of abuse as in case of pregabal
Agomelatine is a melatonergic antidepressant, approved for the treatment of Major Depressive Disorder (MDD) in Europe and Australia,
Agomelatine: An astounding sui-generis antidepressant?
Naveed M, Li LD, Sheng G, Du ZW, Zhou YP, Nan S, Zhu MY, Zhang J, Zhou QG. Naveed M, et al. Curr Mol Pharmacol. 2021 Dec 9. doi: 10.2174/1874467214666211209142546. Online ahead of print. Curr Mol Pharmacol. 2021. PMID: 34886787
Agomelatine is a unique melatonin analog with antidepressant properties and a large therapeutic index that improves clinical safety. ...To sum up, an agomelatine has not only antidepressant properties but also has anxiolytic effects....
Agomelatine is a unique melatonin analog with antidepressant properties and a large therapeutic index that improves clinical safety.
Effects of agomelatine and mirtazapine on sleep disturbances in major depressive disorder: evidence from polysomnographic and resting-state functional connectivity analyses.
Mi WF, Tabarak S, Wang L, Zhang SZ, Lin X, Du LT, Liu Z, Bao YP, Gao XJ, Zhang WH, Wang XQ, Fan TT, Li LZ, Hao XN, Fu Y, Shi Y, Guo LH, Sun HQ, Liu L, Si TM, Zhang HY, Lu L, Li SX. Mi WF, et al. Sleep. 2020 Nov 12;43(11):zsaa092. doi: 10.1093/sleep/zsaa092. Sleep. 2020. PMID: 32406918
To investigate effects of agomelatine and mirtazapine on sleep disturbances in patients with major depressive disorder. ...Functional connectivity (FC) between right dlPFC and left precuneus in mirtazapine group was higher compared with agomelatine group after 8 wee …
To investigate effects of agomelatine and mirtazapine on sleep disturbances in patients with major depressive disorder. ...Functional …
940 results